Natixis’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.05M | Buy |
6,952
+3,980
| +134% | +$604K | ﹤0.01% | 575 |
|
2025
Q1 | $444K | Buy |
+2,972
| New | +$444K | ﹤0.01% | 648 |
|
2024
Q4 | – | Sell |
-3,473
| Closed | -$684K | – | 1052 |
|
2024
Q3 | $684K | Sell |
3,473
-268
| -7% | -$52.8K | ﹤0.01% | 573 |
|
2024
Q2 | $773K | Sell |
3,741
-164
| -4% | -$33.9K | ﹤0.01% | 530 |
|
2024
Q1 | $1.06M | Buy |
+3,905
| New | +$1.06M | 0.01% | 503 |
|
2023
Q2 | – | Sell |
-4,722
| Closed | -$953K | – | 1027 |
|
2023
Q1 | $953K | Buy |
+4,722
| New | +$953K | 0.01% | 522 |
|
2022
Q4 | – | Sell |
-30,625
| Closed | -$6.03M | – | 1060 |
|
2022
Q3 | $6.03M | Buy |
30,625
+27,800
| +984% | +$5.47M | 0.03% | 361 |
|
2022
Q2 | $605K | Sell |
2,825
-42,789
| -94% | -$9.16M | ﹤0.01% | 863 |
|
2022
Q1 | $13M | Buy |
45,614
+30,439
| +201% | +$8.64M | 0.05% | 357 |
|
2021
Q4 | $5.72M | Buy |
15,175
+2,562
| +20% | +$965K | 0.02% | 522 |
|
2021
Q3 | $5.21M | Buy |
12,613
+6,633
| +111% | +$2.74M | 0.02% | 525 |
|
2021
Q2 | $2.21M | Buy |
+5,980
| New | +$2.21M | 0.01% | 508 |
|
2020
Q2 | – | Sell |
-66,200
| Closed | -$8.36M | – | 751 |
|
2020
Q1 | $8.36M | Sell |
66,200
-6,214
| -9% | -$784K | 0.07% | 211 |
|
2019
Q4 | $11M | Sell |
72,414
-35,450
| -33% | -$5.38M | 0.07% | 267 |
|
2019
Q3 | $14.3M | Buy |
107,864
+69,281
| +180% | +$9.17M | 0.09% | 200 |
|
2019
Q2 | $5.48M | Sell |
38,583
-105,076
| -73% | -$14.9M | 0.04% | 310 |
|
2019
Q1 | $20.6M | Buy |
143,659
+92,692
| +182% | +$13.3M | 0.13% | 164 |
|
2018
Q4 | $5.77M | Sell |
50,967
-34,721
| -41% | -$3.93M | 0.05% | 300 |
|
2018
Q3 | $11.5M | Buy |
85,688
+42,666
| +99% | +$5.74M | 0.07% | 257 |
|
2018
Q2 | $4.83M | Buy |
+43,022
| New | +$4.83M | 0.03% | 387 |
|
2017
Q4 | – | Sell |
-3,132
| Closed | -$338K | – | 901 |
|
2017
Q3 | $338K | Sell |
3,132
-46
| -1% | -$4.96K | ﹤0.01% | 849 |
|
2017
Q2 | $321K | Buy |
3,178
+95
| +3% | +$9.6K | ﹤0.01% | 624 |
|
2017
Q1 | $277K | Buy |
+3,083
| New | +$277K | ﹤0.01% | 742 |
|